1. Home
  2. MLYS vs KRT Comparison

MLYS vs KRT Comparison

Compare MLYS & KRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$31.02

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Karat Packaging Inc.

KRT

Karat Packaging Inc.

N/A

Current Price

$48.34

Market Cap

957.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MLYS
KRT
Founded
2019
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
957.7M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
MLYS
KRT
Price
$31.02
$48.34
Analyst Decision
Strong Buy
Sell
Analyst Count
7
2
Target Price
$48.67
$26.50
AVG Volume (30 Days)
841.5K
130.6K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
6.33%
EPS Growth
37.43
4.70
EPS
N/A
1.80
Revenue
N/A
$467,743,000.00
Revenue This Year
N/A
$13.05
Revenue Next Year
N/A
$8.11
P/E Ratio
N/A
$26.88
Revenue Growth
N/A
10.67
52 Week Low
$22.30
$20.61
52 Week High
$47.65
$50.81

Technical Indicators

Market Signals
Indicator
MLYS
KRT
Relative Strength Index (RSI) 70.58 62.59
Support Level $30.96 $22.31
Resistance Level $31.26 $50.74
Average True Range (ATR) 1.38 1.59
MACD 0.50 -0.53
Stochastic Oscillator 92.62 50.66

Price Performance

Historical Comparison
MLYS
KRT

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About KRT Karat Packaging Inc.

Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.

Share on Social Networks: